<code id='8FE6F5BEB8'></code><style id='8FE6F5BEB8'></style>
    • <acronym id='8FE6F5BEB8'></acronym>
      <center id='8FE6F5BEB8'><center id='8FE6F5BEB8'><tfoot id='8FE6F5BEB8'></tfoot></center><abbr id='8FE6F5BEB8'><dir id='8FE6F5BEB8'><tfoot id='8FE6F5BEB8'></tfoot><noframes id='8FE6F5BEB8'>

    • <optgroup id='8FE6F5BEB8'><strike id='8FE6F5BEB8'><sup id='8FE6F5BEB8'></sup></strike><code id='8FE6F5BEB8'></code></optgroup>
        1. <b id='8FE6F5BEB8'><label id='8FE6F5BEB8'><select id='8FE6F5BEB8'><dt id='8FE6F5BEB8'><span id='8FE6F5BEB8'></span></dt></select></label></b><u id='8FE6F5BEB8'></u>
          <i id='8FE6F5BEB8'><strike id='8FE6F5BEB8'><tt id='8FE6F5BEB8'><pre id='8FE6F5BEB8'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:739
          Ivan Cheung
          Ivan Cheung is retiring as chairman of Eisai's U.S. operations and global head of its Alzheimer’s disease unit. Chantal Heijnen for STAT

          Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month. The surprise announcement comes just days after Eisai won final approval in the U.S. for its Alzheimer’s drug Leqembi.

          Cheung will be replaced in his capacity as head of the Alzheimer’s unit by his brother-in-law Keisuke Naito, 34, who is currently chief ecosystem officer and chief strategy officer. He is also the son of Eisai CEO Haruo Naito.

          advertisement

          Tatsuyuki Yasuno, current chief financial officer, will replace Cheung as head of Eisai’s U.S. unit.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          UnitedHealth financials solid despite Change Healthcare cyberattack
          UnitedHealth financials solid despite Change Healthcare cyberattack

          AdobeHospitalsandmedicalgroupssaythey’restillreelingfromtheeffectsofthecyberattackonaUnitedHealthGro

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          The Karikó problem: Lessons for funding basic research

          AdobeNewscientificinstitutesarespringingupallovertheplacethesedays:ArcadiaScience,NewScience,ArcInst